<?xml version="1.0" encoding="UTF-8"?>
<p content-type="flushleft">Human malaria, a reemerging infectious disease, is caused by several types of protozoan parasites of the genus 
 <italic>Plasmodium</italic>. It has been one of the primary concerns to humanity for centuries and is now extended to more than 40% of the world’s population. Our focus will be on the most virulent of such species, 
 <italic>Plasmodium falciparum</italic>. Increasing geographical spread of the species resistant to current drug treatments is a cause of serious concern (
 <xref rid="r1" ref-type="bibr">1</xref>
 <xref rid="r2" ref-type="bibr"/>–
 <xref rid="r3" ref-type="bibr">3</xref>). Characterizing how current antimalarial drugs work at the molecular level is a key for intelligent design of improved antimalarial drugs needed to combat the disease.
</p>
